February 23, 2017 Off

Abivax discovers molecules active against dengue fever

By Dino Mustafić

Abivax, a biotechnology company targeting the immune system to eliminate viral diseases, has recently discovered several molecules that are active against the virus in vitro, some of which could be developed as therapeutic drug-candidates against dengue fever.

February 23, 2017 Off

Novartis’s cancer drug wins FDA’s sNDA, priority review and breakthrough therapy designation

By Dino Mustafić

US Food and Drug Administration (FDA) has accepted Novartis’s supplemental New Drug Application (sNDA) for filing, and granted Priority Review for the expanded use of Zykadia (ceritinib) as a first-line treatment for patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.

February 23, 2017 Off

A survey finds constantly checking electronic devices linked to significant stress for most Americans

By Dino Mustafić

A decade after the emergence of smartphones, Facebook and Twitter, more than four out of five adults in the U.S. report that they constantly or often check their email, texts and social media accounts, according to part two of the American Psychological Association’s (APA) report Stress in America: Coping with Change. This attachment to devices and the constant use of technology is associated with higher stress levels for these Americans.